27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Gainers
• Moleculin Biotech, Inc. (NASDAQ:MBRX) shares moved upwards by 35.2% to $1.19 during Wednesday's pre-market session.
• Arbutus Biopharma, Inc. (NASDAQ:ABUS) shares surged 33.1% to $3.74. The most recent rating by JMP Securities, on February 05, is at Market Outperform, with a price target of $10.00.
• Qiagen, Inc. (NYSE:QGEN) shares rose 6.4% to $35.30. The most recent rating by UBS, on January 10, is at Neutral, with a price target of $36.00.
• Onconova Therapeutics, Inc. (NASDAQ:ONTX) stock rose 5.6% to $0.40.
• Vaxart, Inc. (NASDAQ:VXRT) stock rose 5.1% to $1.24.
Losers
• ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) shares decreased by 14.0% to $3.50 during Wednesday's pre-market session.
• Biocept, Inc. (NASDAQ:BIOC) stock plummeted 4.7% to $0.31.
• Acasti Pharma, Inc. (NASDAQ:ACST) shares plummeted 4.3% to $0.78. The most recent rating by B. Riley FBR, on January 13, is at Neutral, with a price target of $2.00.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!